Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Papamichail

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Stem Cells (Dayton, Ohio)|August 20, 2005
Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cellsPanagiota A Sotiropoulou, Sonia A Perez, Maria Salagianni, et al.
Stem Cells (Dayton, Ohio)|January 28, 2006
Cell culture medium composition and translational adult bone marrow-derived stem cell researchPanagiota A Sotiropoulou, Sonia A Perez, Maria Salagianni, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2011
Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and functionArdiana Moustaki, Kimon V Argyropoulos, Constantin N Baxevanis, et al.
Stem Cells (Dayton, Ohio)|August 16, 2005
Interactions between human mesenchymal stem cells and natural killer cellsPanagiota A Sotiropoulou, Sonia A Perez, Angelos D Gritzapis, et al.
International Journal of Cancer|April 12, 2002
HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytesConstantin N Baxevanis, Angelos D Gritzapis, Ourania E Tsitsilonis, et al.
Oncoimmunology|September 14, 2016
MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cellsEleftheria A Anastasopoulou, Ioannis F Voutsas, Michael Papamichail, et al.
Immunotherapy|July 20, 2010
HER-2/neu as a target for cancer vaccinesConstantin N Baxevanis, Ioannis F Voutsas, Angelos D Gritzapis, et al.
Neuroimmunomodulation|July 14, 2004
Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2)Costas Phenekos, Andromachi Vryonidou, Angelos D Gritzapis, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 17, 2004
Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA)Ourania E Tsitsilonis, Apollon Thrasyvoulides, Apostolos Balafas, et al.
Expert Review of Molecular Diagnostics|October 28, 2014
Immune biomarkers: how well do they serve prognosis in human cancers?Constantin N Baxevanis, Eleftheria A Anastasopoulou, Ioannis F Voutsas, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Stem Cells (Dayton, Ohio)|August 20, 2005
Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cellsPanagiota A Sotiropoulou, Sonia A Perez, Maria Salagianni, et al.
Stem Cells (Dayton, Ohio)|January 28, 2006
Cell culture medium composition and translational adult bone marrow-derived stem cell researchPanagiota A Sotiropoulou, Sonia A Perez, Maria Salagianni, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2011
Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and functionArdiana Moustaki, Kimon V Argyropoulos, Constantin N Baxevanis, et al.
Stem Cells (Dayton, Ohio)|August 16, 2005
Interactions between human mesenchymal stem cells and natural killer cellsPanagiota A Sotiropoulou, Sonia A Perez, Angelos D Gritzapis, et al.
International Journal of Cancer|April 12, 2002
HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytesConstantin N Baxevanis, Angelos D Gritzapis, Ourania E Tsitsilonis, et al.
Oncoimmunology|September 14, 2016
MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cellsEleftheria A Anastasopoulou, Ioannis F Voutsas, Michael Papamichail, et al.
Immunotherapy|July 20, 2010
HER-2/neu as a target for cancer vaccinesConstantin N Baxevanis, Ioannis F Voutsas, Angelos D Gritzapis, et al.
Neuroimmunomodulation|July 14, 2004
Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2)Costas Phenekos, Andromachi Vryonidou, Angelos D Gritzapis, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 17, 2004
Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA)Ourania E Tsitsilonis, Apollon Thrasyvoulides, Apostolos Balafas, et al.
Expert Review of Molecular Diagnostics|October 28, 2014
Immune biomarkers: how well do they serve prognosis in human cancers?Constantin N Baxevanis, Eleftheria A Anastasopoulou, Ioannis F Voutsas, et al.
Pageof 7